1-10 of 10
Angela Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Results of a Randomized Placebo Controlled Trial of Inhaled Mometasone to Promote Reduction in Vaso-Occlusive Events (IMPROVE-II)

Susanna Curtis, Elizabeth Stidham, Robyn T. Cohen, Angela Liu, Marc Probst, Tiffany Mitchell, George Loo, Jordan Bellis, Chiemika Ihiasota, Jeffrey A. Glassberg
Journal: Blood
Blood (2023) 142 (Supplement 1): 1126.
https://doi.org/10.1182/blood-2023-189852
Published: 2023
Journal Articles

Efficient and Specific Multi-Locus Editing of Allogeneic CAR T Cells for Hypoimmunity during Large Scale Manufacture Using Cas12b

Christina Chaivorapol, Pascal Beauchesne, Rowena De Jesus, William E Dowdle, Xiaoyu Chen, Alison Bayley, Yunjiang Qiu, Andrew Birnberg, Yu Zheng, Antonino Montalbano, Angela Liu, Misbah Zafar, Karl Manner, Ramya Ankala, Eleonore Tham, Heer Shah, Ben Lam, Jaclyn Lock, Lindong Weng, Kate Watts, Amanda Valdiosera, Kimberly Davis, Lei Wang, Divy Kangeyan, PhD, Nicolas Devos, Athena Wong, Jason Lih, Edward J Rebar
Journal: Blood
Blood (2022) 140 (Supplement 1): 1606–1607.
https://doi.org/10.1182/blood-2022-167627
Published: 2022
Journal Articles

Plasma Free Hemoglobin Is Associated with LDH, AST, Total Bilirubin, and the Hemolytic Component in Patients with Sickle Cell Anemia

Angela Liu, Susanna Curtis, Paola Sebastiani, Donald Brambilla, Jeffrey A. Glassberg
Journal: Blood
Blood (2022) 140 (Supplement 1): 5438–5439.
https://doi.org/10.1182/blood-2022-158713
Published: 2022
Journal Articles

Characterization of Myeloid Neoplasms in Inflammatory Bowel Disease

Daniel I Nathan, David Mueller, Angela Liu, John Mascarenhas, Bridget K Marcellino
Journal: Blood
Blood (2022) 140 (Supplement 1): 4056–4057.
https://doi.org/10.1182/blood-2022-160476
Published: 2022
Journal Articles

Race, rituximab, and relapse in TTP

Clinical Trials & Observations
Shruti Chaturvedi, Ana G. Antun, Andrew M. Farland, Ryan Woods, Ara Metjian, Yara A. Park, Gustaaf de Ridder, Briana Gibson, Raj S. Kasthuri, Darla K. Liles, Frank Akwaa, Todd Clover, Lisa Baumann Kreuziger, J. Evan Sadler, Meera Sridharan, Ronald S. Go, Keith R. McCrae, Harsh Vardhan Upreti, Angela Liu, Ming Y. Lim, Radhika Gangaraju, X. Long Zheng, Jay S. Raval, Camila Masias, Spero R. Cataland, Andrew Johnson, Elizabeth Davis, Michael D. Evans, Marshall A. Mazepa, for the United States Thrombotic Microangiopathies Consortium
Journal: Blood
Blood (2022) 140 (12): 1335–1344.
https://doi.org/10.1182/blood.2022016640
Published: 2022
Includes: Supplemental data
Journal Articles

African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic Purpura

Angela Liu, Marshall Mazepa, MD, Elizabeth Davis, MD, Andrew Johnson, MD, Ana G Antun, MD, Andrew M. Farland, MD, Ryan R Woods, MD, Ara Metjian, MD, Kristin Bagby, Yara Park, MD, Jay S Raval, MD, Gustaaf de Ridder, MD, Briana Gibson, MD, Raj S. Kasthuri, MD, Darla K Liles, MD, Susan Eubanks, Frank Akwaa, MD, Lisa Baumann Kreuziger, MD MS, J Evan Sadler, Meera Sridharan, MD, Ronald S. Go, MD, Rahil Kohli, MD, Harsh Vardhan Upreti, Keith R McCrae, MD, Ming Y. Lim, MBBChir,MA, X. Long Zheng, MD, PhD, Nicole K. Kocher, Radhika Gangaraju, MD, Spero Cataland, MD, Shruti Chaturvedi, MBBS,MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 1066.
https://doi.org/10.1182/blood-2019-131064
Published: 2019
Journal Articles

Activity of Oral Panobinostat (LBH589) in Patients with Myelofibrosis.

Daniel J. DeAngelo, MD, PhD, Andrew Spencer, Thomas Fischer, MD, Thomas Kindler, MD, Oliver G. Ottmann, MD, Miles Prince, MD, Frank J. Giles, MD, MB, FRCPI, FRCPath, Jorge Cortes, MD, Angela Liu, PharmD, Kathryn Parker, PhD, Ying Yan, Jeffrey W. Scott, Kapil N. Bhalla, MD
Journal: Blood
Blood (2009) 114 (22): 2898.
https://doi.org/10.1182/blood.V114.22.2898.2898
Published: 2009
Journal Articles

Phase IA/II Study of Oral Panobinostat (LBH589), a Novel Pan- Deacetylase Inhibitor (DACi) Demonstrating Efficacy in Patients with Advanced Hematologic Malignancies.

Oliver G. Ottmann, MD, Andrew Spencer, H. Miles Prince, Kapil N. Bhalla, Thomas Fischer, Angela Liu, Kathryn Parker, Muhammad Jalaluddin, Glen Laird, Margaret Woo, Jeffrey W. Scott, Daniel J. DeAngelo
Journal: Blood
Blood (2008) 112 (11): 958.
https://doi.org/10.1182/blood.V112.11.958.958
Published: 2008
Journal Articles

Phase IA/II Study of Oral LBH589, a Novel Deacetylase Inhibitor (DACi), Administered on 2 Schedules, in Patients with Advanced Hematologic Malignancies.

Andrew Spencer, MD, Miles Prince, MD, Daniel J. DeAngelo, MD, Thomas Fischer, MD, Kapil N. Bhalla, MD, Francis J. Giles, MB, MD, FRCPI, FRCPa, Angela Liu, PharmD, Kathryn Parker, PhD, Glen Laird, PhD, Eric Masson, PharmD, John Rediske, PhD, Jeffrey W. Scott, PhD, Oliver G. Ottmann, MD
Journal: Blood
Blood (2007) 110 (11): 907.
https://doi.org/10.1182/blood.V110.11.907.907
Published: 2007
Journal Articles

Laboratory Tumor Lysis Syndrome Complicating LBH589 Therapy in a Patient with Acute Myeloid Leukemia.

Anna Kalff, MBBS, Jake Shortt, MBBS, Julia Farr, Roger McLennan, MBBS, Jeffrey W. Scott, Angela Liu, Andrew Spencer, MBBS
Journal: Blood
Blood (2006) 108 (11): 4554.
https://doi.org/10.1182/blood.V108.11.4554.4554
Published: 2006